Copyright
©2011 Baishideng Publishing Group Co.
World J Gastroenterol. Apr 7, 2011; 17(13): 1779-1786
Published online Apr 7, 2011. doi: 10.3748/wjg.v17.i13.1779
Published online Apr 7, 2011. doi: 10.3748/wjg.v17.i13.1779
Table 1 Nutrition risk screening
Non-risk | P | At-risk | P | |||
NS | NNS | NS | NNS | |||
Patient number | 143 | 5 | 49 | 2 | ||
Diagnosis (colon / rectal cancer) | 50/93 | 1/4 | 24/25 | 2/0 | ||
Gender (male/female) | 63/80 | 2/3 | 0.893 | 30/19 | 2/0 | 0.088 |
Tumor stage1 | 0.066 | 0.358 | ||||
Complications2 | 1.23 ± 0.60 | 2.40 ± 1.51 | 0.000 | 1.20 ± 0.45 | 1.50 ± 0.70 | 0.348 |
None (= 1) | ||||||
Infection (= 2) | ||||||
Fistula (= 3) | ||||||
Others (= 4) | ||||||
Postoperative hospital stay (d) | 15.27 ± 5.89 | 23.00 ± 15.84 | 0.009 | 14.55 ± 4.11 | 14.50 ± 2.12 | 0.986 |
Cost of hospitalization (RMB Yuan) | 43 469.88 ± 9961.67 | 35 825.00 ± 16 271.94 | 0.301 | 41 802.97 ± 13 300. 99 | 33 845.80 ± 8374.80 | 0.187 |
Postoperative outcome2 | 1.02 ± 0.16 | 1.00 ± 0.00 | 0.707 | 1.10 ± 0.30 | 1.50 ± 0.70 | 0.090 |
Table 2 Preoperative total parenteral nutrition in malnourished patients
Group 1 | Group 2 | P | |
Patient number | 2 | 3 | |
Diagnosis (colon/rectal cancer) | 2/0 | 1/2 | |
Gender (male/female) | 2/0 | 1/2 | 0.219 |
Tumor stage | 1 | 2 | |
Preoperative albumin (g/L) | 36.30 ± 5.65 | 32.83 ± 9.00 | 0.669 |
Preoperative potassium (mmol/L) | 4.53 ± 0.36 | 3.75 ± 0.92 | 0.352 |
Preoperative sodium (mmol/L) | 138.45 ± 2.05 | 142.13 ± 3.40 | 0.274 |
Postoperative EN | 2 | 0 | |
Postoperative TPN | 2 | 2 | |
Postoperative TPN duration (d) | 7.00 ± 1.41 | 3.66 ± 3.2 | 0.276 |
POD1a serum glucose (mmol/L) | 6.91 ± 1.11 | 9.05 ± 3.65 | 0.498 |
POD1 albumin (g/L) | 27.80 ± 3.11 | 26.13 ± 3.19 | 0.605 |
POD1 potassium (mmol/L) | 4.49 ± 0.36 | 4.45 ± 0.78 | 0.953 |
POD1 sodium (mmol/L) | 135.8 ± 3.11 | 137.66 ± 2.51 | 0.508 |
POD5a serum glucose (mmol/L) | 6.29 ± 0.24 | 6.39 ± 2.88 | 0.968 |
POD5 albumin (g/L) | 28.65 ± 5.16 | 32.33 ± 4.67 | 0.466 |
POD5 potassium (mmol/L) | 4.67 ± 0.11 | 4.42 ± 0.12 | 0.115 |
POD5 sodium (mmol/L) | 135.95 ± 1.34 | 135.93 ± 2.72 | 0.994 |
Complications | 0.445 | ||
Postoperative hospital stay(d) | 10.50 ± 4.94 | 13.00 ± 2.64 | 0.500 |
Cost of hospitalization (RMB) | 62713.50 ± 5070.66 | 43178.00 ± 3596.68 | 0.014 |
Postoperative outcome | 0.495 |
Table 3 Postoperative enteral nutrition and clinical outcome
Group 1 | Group 2 | P | |
Patient number | 25 | 174 | |
Diagnosis (colon /rectal cancer) | 8/17 | 66/108 | 0.568 |
Gender (male/female) | 9/16 | 91/83 | 0.129 |
Tumor stage | 0.777 | ||
NRS 2002 score | 1.88 ± 0.88 | 1.96 ± 1.01 | 0.689 |
Postoperative fasting time (d) | 5.16 ± 1.21 | 6.40 ± 1.84 | 0.001 |
Postoperative TPN | 27 | 167 | 0.996 |
Complications | 1.04 ± 0.20 | 1.29 ± 0.66 | 0.060 |
None (= 1) | |||
Infection (= 2) | |||
Fistula (= 3) | |||
Others (= 4) | |||
Postoperative hospital stay (d) | 11.92 ± 4.34 | 15.77 ± 6.03 | 0.002 |
Cost of hospitalization (RMB) | 44210.88 ± 7635.85 | 42060.09 ± 13066.15 | 0.752 |
Postoperative outcome | 1.00 ± 0.00 | 1.06 ± 0.27 | 0.214 |
Recovery (= 1) | |||
Unrecovery (= 2) | |||
Dead (= 3) |
Table 4 Postoperative total parenteral nutrition duration
Group 1 | Group 2 | P | |
Patient number | 66 | 108 | |
Diagnosis (colon/rectal cancer) | 31/35 | 35/73 | |
Gender (male/female) | 32/34 | 59/49 | 0.434 |
Tumor stage | 0.493 | ||
NRS 2002 score | 1.92 ± 0.94 | 1.99 ± 1.05 | 0.676 |
Preoperative serum glucose (mmol/L) | 6.10 ± 1.86 | 5.75 ± 1.17 | 0.134 |
Preoperative albumin (g/L) | 38.47 ± 4.44 | 39.51 ± 6.37 | 0.249 |
Preoperative potassium (mmol/L) | 3.98 ± 0.38 | 6.57 ± 1.84 | 0.270 |
Preoperative sodium (mmol/L) | 140.98 ± 3.23 | 139.58 ± 14.1 | 0.435 |
POD1 serum glucose (mmol/L) | 8.59 ± 3.39 | 7.37 ± 2.06 | 0.100 |
POD1 albumin (g/L) | 32.24 ± 3.65 | 35.49 ± 4.11 | 0.725 |
POD1 potassium (mmol/L) | 4.05 ± 0.44 | 3.99 ± 0.45 | 0.424 |
POD1 sodium (mmol/L) | 136.35 ± 3.59 | 135.72 ± 14.50 | 0.763 |
POD5 serum glucose (mmol/L) | 7.59 ± 3.57 | 6.48 ± 1.32 | 0.006 |
POD5 albumin (g/L) | 31.79 ± 3.53 | 39.91 ± 3.66 | 0.063 |
POD5 potassium (mmol/L) | 4.21 ± 0.50 | 4.16 ± 0.53 | 0.553 |
POD5 sodium (mmol/L) | 136.5 ± 18.60 | 137.84 ± 2.81 | 0.348 |
Complications | 0.533 | ||
Postoperative hospital stay (d) | 15.59 ± 5.32 | 15.87 ± 6.45 | 0.761 |
Cost of hospitalization (RMB) | 47724.14 ± 16945.17 | 38598.73 ± 8349.79 | 0.000 |
Postoperative outcome | 0.166 |
Table 5 Postoperative administration of omega-3 fatty acids
Group 1 | Group 2 | P | |
Patient number | 102 | 65 | |
Diagnosis (colon /rectal cancer) | 42/60 | 40/25 | |
Gender (male/female) | 49/53 | 45/38 | 0.089 |
Tumor stage | 0.317 | ||
NRS 2002 score | 1.94 ± 0.87 | 2.00 ± 1.15 | 0.710 |
Preoperative total lymphocyte count | 1.80 ± 0.63 | 1.93 ± 0.59 | 0.186 |
POD1 total lymphocyte count | 0.99 ± 0.34 | 1.11 ± 0.40 | 0.067 |
POD5 total lymphocyte count | 1.26 ± 0.59 | 1.29 ± 0.35 | 0.660 |
Complications | 1.33 ± 0.64 | 1.13 ± 0.49 | 0.041 |
None (= 1) | |||
Infection (= 2) | |||
Fistula (= 3) | |||
Others (= 4) | |||
Postoperative hospital stay (d) | 16.04 ± 5.81 | 14.81 ± 4.29 | 0.159 |
Cost of hospitalization (RMB) | 43936.75 ± 14260.31 | 39938.89 ± 10741.40 | 0.055 |
Postoperative outcome | 1.09 ± 0.33 | 1.06 ± 0.27 | 0.055 |
Recovery (= 1) | |||
Unrecovery (= 2) | |||
Dead (= 3) |
- Citation: Chen Y, Liu BL, Shang B, Chen AS, Liu SQ, Sun W, Yin HZ, Yin JQ, Su Q. Nutrition support in surgical patients with colorectal cancer. World J Gastroenterol 2011; 17(13): 1779-1786
- URL: https://www.wjgnet.com/1007-9327/full/v17/i13/1779.htm
- DOI: https://dx.doi.org/10.3748/wjg.v17.i13.1779